+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuromuscular Disease Drug"

Global Neuromuscular Disease Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Neuromuscular Disease Therapeutics Market 2023-2027

  • Report
  • October 2023
  • 163 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

The Neuromuscular Disease Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat diseases of the nervous system. Neuromuscular Disease Drugs are used to treat diseases that affect the muscles, such as muscular dystrophy, myasthenia gravis, and amyotrophic lateral sclerosis (ALS). These drugs can be used to reduce muscle weakness, improve muscle strength, and slow the progression of the disease. Commonly used drugs include corticosteroids, immunosuppressants, and anticholinesterase agents. Some companies in the Neuromuscular Disease Drug market include Biogen, Novartis, Merck, and Pfizer. These companies develop and market drugs to treat neuromuscular diseases, as well as other diseases of the nervous system. Show Less Read more